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Background: Excessive manganese exposure induced cognitive deficit. Several lines of evidence have
demonstrated that taurine improves cognitive impairment induced by numerous neurotoxins. However, the role of
taurine on manganese-induced damages in learning and memory is still elusive. This goal of this study was to
investigate the beneficial effect of taurine on learning and memory capacity impairment by manganese exposure in
an animal model.
Results: The escape latency in the Morris Water Maze test was significantly longer in the rats injected with
manganese than that in the rats received both taurine and manganese. Similarly, the probe trial showed that the
annulus crossings were significantly greater in the taurine plus manganese treated rats than those in the
manganese-treated rats. However, the blood level of manganese was not altered by the taurine treatment.
Interestingly, the exposure of manganese led to a significant increase in the acetylcholinesterase activity and an
evidently decrease in the choline acetyltransferase activity, which were partially restored by the addition of taurine.
Additionally, we identified 9 differentially expressed proteins between the rat hippocampus treated by manganese
and the control or the manganese plus taurine in the proteomic analysis using the 2-dimensional gel electrophoresis
followed by the tandem mass spectrometry (MS/MS). Most of these proteins play a role in energy metabolism,
oxidative stress, inflammation, and neuron synapse.
Conclusions: In summary, taurine restores the activity of AChE and ChAT, which are critical for the regulation of
acetylcholine. We have identified seven differentially expressed proteins specifically induced by manganese and two
proteins induced by taurine from the rat hippocampus. Our results support that taurine improves the impaired learning
and memory ability caused by excessive exposure of manganese.Background
Manganese (Mn) is an essential nutrient involved in the
regulation of multiple metabolic pathways. However, Mn
can be toxic to many organs at a high concentration.
The brain is particularly susceptible to the Mn toxicity.
Excessive occupational or environmental Mn exposure is
associated with multiple neurotoxic effects. Early neu-
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unless otherwise stated.concentration, and spatial orientation are also observed
in patients with Mn poisoning [1-3]. Unfortunately, the
available treatment option for Mn poisoning is still very
limited. L-3,4-dihydroxyphenylalanine (L-dopa) has been
demonstrated possessing some therapeutic effects against
Mn-poisoning but it fails to improve the parkinsonism-
like symptoms such as walk time, tapping hand in manga-
nese exposure welders [4]. Chelation agents like EDTA or
para-aminosalicylic acid (PAS) have also been used to treat
Mn poisoning. However, past studies have reported some
conflicting results of EDTA about its therapeutic effects
on manganism [5,6]. Therefore, it is very important to de-
velop an effective therapy to prevent permanent neuro-
logical damages mediated by manganese at early stage.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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acids that is widely distributed in human body, including
blood plasma, heart, muscle, and brain tissue. Previous
studies have reported that taurine has a neuroprotective
effect against L-glutamate-induced excitotoxicity [7]. Tau-
rine supplementation has been shown to benefit neuronal
proliferation and synaptogenesis, suggesting its effects on
enhancing synaptic plasticity and improving learning and
memory [8]. Taurine has also been reported to improve
the symptoms of metal-induced intoxication for lead and
cadmium [9-11]. No severe side effects have been associ-
ated with taurine treatment. However, the effects of tau-
rine on the learning and memory impairment induced by
manganese exposure is still unknown.
In this study, we aimed to examine the role of taurine
against Mn poisoning with a focus on the spatial learning
and memory function in a rat model. We also explored the
molecular mechanism of taurine in alleviating the Mn-
induced neurological symptoms by evaluating acetylcholine
synthesis and degradation. In addition, we conducted a sys-
tematic proteomic analysis by mass spectrometry to gain
an insight into the genome-wide taurine-specific change in
the protein expression profile. Our results provided novel




60 male Sprague-Dawley rats weight (120 ± 10) g
(approximately 6 weeks of age) were obtained from
the experimental animal center of Guangxi Medical
University (License No:SCXKGui2009-0002). All rats
were supplied local tap water ad libitum, which con-
tained the level of Mn that was below the detection
limit. Rats were randomly assigned into 3 groups
(20 rats/group): control, Mn, and taurine plus Mn group.
Mn-administrated rats were injected intraperitoneally by
15 mg/kg MnCl2· 4H2O daily for 8 weeks. The rats in
the taurine plus Mn group were injected intraperitone-
ally for 15 mg MnCl2· 4H2O/kg and 200 mg taurine/kg
daily for 8 weeks. All rats were weighed daily to calculate
the dosage of manganese and taurine treatment. Control
animals received daily physiological saline injection for 8
weeks. All solutions were prepared with Milli-Q™ water.
The procedures of animal experiments were in accord-
ance with the protocols approved by the ethical commit-
tee for animal experiment of the Guangxi Medical
University (GXMU-2014-036).
Morris water maze
The Morris Water Maze was carried out within 24 h
after last injection and was used to assess animal learn-
ing and memory ability [12]. The water maze used in
our study was a flat black galvanized metal tank that was210 cm in diameter and equipped with a platform 1–2 cm
below the surface of the water. A camera was mounted
above the maze and connected to a computer equipped
with the Morris Water Maze analysis software (Huaibei
Zhenghua biological equipment Co. China) to record the
swimming track in the water maze. Before the learning
trail, animals were placed on the fixed platform for 10s to
familiarize themselves with the task. The animals facing to
the pool wall were then trained to find the fixed platform
from different locations (N, S, E, W) around the edge of
the pool every day for 7 days. The trial was terminated
once the animals reach the platform. If the animals failed
to locate the platform within 90s, the animal was placed
on the platform and the latency was recorded as 90s. The
time(s), swimming distance (cm), and speed (cm/s) of es-
cape latency to find the platform was used to evaluate the
animal spatial memory. A surroundings and visual objects
were positioned at fixed locations to serve as cues for the
platform location. On day 8, a spatial probe trial was con-
ducted with the original platform removed. The cumula-
tive times spending in the original platform location was
recorded during a period of 90s.
Blood manganese level measurement
24 h after Morris Water Maze test, the animals were
euthanized with pentobarbital (10 mg/kg). The blood of
heart were immediately collected in polystyrene tubes
which were previously washed by 10% HNO3 (Ultrapure
grade, sigma, America) for 24 h and stored at −80°C until
Mn analyses were conducted. 1 ml blood were digested
with 3 ml HNO3 (65%) for 24 h at 130°C. The Inductively
Coupled Plasma Atomic Emission Spectroscopy (ICP-
AES) was used to analyze the level of manganese.
Determination of acetylcholinesterase (AChE) and choline
acetyltransferase (ChAT) activity
The measurement of AChE activity was based on the reac-
tion of thiocholine, resulting from the enzymatic hydroly-
sis of acylthiocholines with 5, 5' dithiobis-2-nitrobenzoic
acid (DTNB). The reaction solution was read at 412 nm
and the enzyme activity was calculated in unit per gram of
input protein. The activity of ChAT was determined by
the ACh synthesis reaction that ChAT catalyzed (Acetyl-
CoA + choline - > Acetylcholine + Co-enzyme A). The ex-
periment were performed according to the instruction of
the ChAT activity kit (Nanjing Jiancheng Bioengineering
Institute, China). The wavelength of spectrometer reading
was at 324 nm. The activity of ChAT was expressed in
unit per wet weight of hippocampus.
Protein sample preparation for rat hippocampus
Hippocampus of rats in the control, Mn and taurine plus
Mn groups were dissected and lysed by the protein ex-
traction buffer containing 20 mM Tris, 7 M urea, 2 M
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ampholyte (4–7) and one tablet of protease inhibitors
(Roche Diagnostics). Hippocampus were homogenized
and centrifuged at 50 000 × g for 120 min. The super-
natant were collected and the protein concentration in
the supernatant was determined by the Bradford method
(BioRad).Two-dimensional gel electrophoresis
Isoelectric focusing was carried out by using the ETTAN
IPGPhor apparatus (GE Healthcare) in Immobiline
Dry Strip holders followed by approximately 750 μg
protein loaded in ready strip. Briefly, a 24 cm pH
4-7 strip (GE Healthcare) was hydrated, focused,
then equilibraten twice in equilibration buffer for 15
min. The IEF strips were placed on top of the 12.5%
homogeneous polyacrylamide gels (26 cm-w 20 cm-h
1.0 mm-thick) in an Ettan DALT12 (GE Healthcare)
gel apparatus. After the second-dimensional separ-
ation finish, the SDS-polyacrylamide gels were fixed
and stained with silver nitrate. Gels were scanned
on ProXpress CCD scanner (Perkin-Elmer). The im-
ages were then captured and analyzed by the Image
Master 2D platinum 5.0 software, including back-
ground adjustment, landmark annotation, protein
spot matching and points of difference analysis. At
least three independent experiments were conducted
for each group.Protein identification and analysis
The candidate protein spots were resected and dehy-
drated. The supernatant of rehydrated samples were
then collected and analyzed in a time-of-flight mass
spectrometer (Voyager DE-Pro Applied Biosystem). Pep-
tide matching and protein searches were performed in
the Swiss-prot database using MASCOT software. The
analysis of the biological functions of identified proteins
was based on the protein databases of Uniprot, Kegg
pathway, Pathwe classification system, and literature
search.Statistical analysis
Results were reported as mean ± SEM. The repeated-
measures ANOVA was used for the analysis of the es-
cape latency, swimming distance and speed among
different groups. Bonferroni’s multiple comparison tests,
one-way ANOVA followed by a correlation coefficient
calculation were used for statistical analysis of probe
times, blood manganese and AChE and ChAT activity.
A p value less than 0.05 is considered as statistically
significant.Results
The effect of taurine in manganese-induced memory and
learning impairment
To test the effects of taurine in manganese-induced
memory and spatial learning impairments, we performed
the Morris Water Maze test. The acquisition trial of the
MWM task is used to assess learning capacity, which is
composed of the escape latency (time required to reach
the platform) and the swimming distance to the plat-
form. The probe trial is a method to measure the mem-
ory ability, which can be evaluated by the time spent in
different areas of the pool or the number of target area
crossings. A repeated-measure ANOVA revealed a sig-
nificant difference in the escape latency (F(2,15) = 9.8,
p < 0.05, Figure 1A) and swimming speed (F(2,15) = 16.8,
p < 0.01, Figure 1B) but not the swimming distance
(F(2,15) = 2.31, p > 0.05, Figure 1C) among the control,
manganese and taurine plus manganese groups. The mean
escape latency over a period of 7 days for the control
group (31.3 ± 3.2 s) and taurine plus manganese group
(30.1 ± 3.2 s) were significantly shorter than that of the
manganese alone group (48.0 ± 3.2 s) (Adjustment mul-
tiple comparisons: Bonferroni, p < 0.01). The mean swim-
ming speed of the control group (11.9 ± 0.3 mm/s) and
taurine plus manganese group (12.2 ± 0.3 mm/s) was sig-
nificantly faster than the manganese alone group (10.0 ±
0.3 mm/s) (multiple comparisons: Bonferroni, p < 0.05). In
the probe trial on day 8, statistical analysis of the annulus
crossings above the original platform position showed a
significant improvement in the taurine plus manganese
group compared to the manganese alone group (F(2,15) =
4.3, p < 0.05). Post hoc analysis indicated that the probe
trial in the control and the taurine plus manganese group
has an increase in the annulus crossings compared to that
of the manganese alone group (control = 7.5 ± 1.8; taurine +
manganese = 6.5 ± 1.5; manganese = 2.0 ± 0.9; least significant
difference test, p < 0.05, Figure 1D).
The effect of taurine on the blood level of manganese
To test if the protective role of taurine in manganese-
induced neurotoxicity is achieved by reducing the level of
manganese in blood, we measured the blood manganese
level by the Atomic Emission Spectroscopy. After 8 weeks
of treatments, the blood manganese level was significantly
higher in the manganese-administrated group than that in
the control group (p = 0.000). However, the addition of tau-
rine failed to reduce the blood manganese level, suggesting
that taurine attenuates manganese-induced toxicity without
affecting the level of manganese in blood (Figure 2A).
The effect of manganese and taurine on the activity of
acetylcholinesterase and choline acetyltransferase
The neurotransmitter acetylcholine has been long asso-
ciated with the learning and memory in past studies.
Figure 1 Evaluation of rat learning and memory in the Morris Water Maze. (A) Mean escape latency to the platform in the Morris water
maze. (B) Mean swimming speed to the platform in the Morris water maze. (C) Mean cumulative distance in the Morris water maze. (D) Spatial
memory retention in the Morris water maze probe trials among different groups. The test was conducted in the same way as the acquisition
trials with the platform absent and 60s-trial limitation. The measure expressed is platform crossings ± S.E. Mn = 6-9. **p Mn versus control;
*p < 0.05 versus Mn rats.
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by the balance between the acetylcholinesterase (AChE)-
mediated ACh degradation and the choline acetyltransferase
(ChAT)-mediated ACh synthesis, we decided to measure
the activity of both enzymes. The activity of AChE in
manganese group (0.40 ± 0.26 U/mg) was not significantly
different from that in the control group (0.29 ± 0.10 U/mg).
However, the combined taurine and manganese treatment
significantly reduced the activity of AChE (0.20 ± 0.04 IU/mg)
compared to the manganese alone treatment (p = 0.032).
The activity of ChAT was dramatically decreased after
manganese treatment (control = 30.27 ± 9.47 IU/g; Mn =
13.24 ± 5.09 IU/g, p = 0.001). Administration of taurine
(20.88 ± 9.50 IU/g) restored ChAT activity to 79% of
control (Figure 2B).Proteomic analysis of the differences between the taurine
and manganese treated rat hippocampus
We observed a total of 849 pairs of protein spots and 12
protein spots alteration when comparing the 2-D gels be-
tween the control and the manganese-treated samples
(Figure 3A Mn). The identity of the 7 alterative spots were
then revealed by mass spectrometry (L-lactate dehydro-
genase B chain, mu-crystallin homolog, peroxiredoxin-6,
actin-related protein 3 homolog, calreticulin precursor,
secernin-1, dynactin subunit 3 isoform B). In addition,
785 pairs of protein spots were matched between the
manganese-treated rat hippocampus and the manganese
plus taurine treated rat hippocampus, while 2 alterative
protein spots were successfully identified (prepro-A-type
allatostatin(N) and glial fibrillary acidic protein delta,
Figure 2 Determination of manganese content in blood and the activity of acetylcholinesterase and choline acetyltransferase in
hippocampus. (A) Mean blood manganese level for different treatment groups (n = 8). * p < 0.05 versus control rats. (B) The comparison of
acetylcholinesterase and choline acetyltransferase activity among different treatment groups (n = 8).
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proteins identified in this study was listed in Table 1.
Discussion
Taurine has also been shown to have neuroprotective ef-
fects in many pathological conditions such as Alzheimer’s
and Huntington’s diseases [13,14]. However, the role of
taurine in manganese-induced neurotoxicity has not been
reported. Research has showed that accumulation of man-
ganese in the brain disturbed the homeostasis of taurine
by significantly increasing taurine uptake in rat astrocytes,
suggesting a potential benefit of taurine in manganese
overload [15]. In our study, Administration of 200 mg/kg/d
of taurine significantly increased the ability of rats in the
Morris Water Maze test. These results provided evidences
to support the protective role of taurine in manganese-
induced spatial learning impairment.
Previous research has shown that taurine formed less
stable metal complexes with transition metals, such as
Cu2+, Co2+, Cd2+, Fe2+, Mn2+, and Mg2+ than other amino
acids [16]. In this study, we also examined whether taurine
is able to chelate manganese from blood. Our result indi-
cated that taurine had no effect on the blood manganese
level, which is consistent to previous reports that taurine
can’t remove lead from blood, kidney, liver and brain [17].
This results suggested that taurine reduces manganese-
induced neurotoxicity without affecting the level of man-
ganese in blood.
Taurine functions as a neuromodulator to attenuate
glutamate-induced neurotoxicity in the central nervous
system [18,19]. Numerous evidences have demonstrated
that acetylcholine is strongly linked to the normal function
of learning and memory [20,21]. The effects of manganeseon the activity of AChE and ChAT, which are important
indicators for the regulation of acetylcholine level in the
brain, have been inconsistent [22-26]. We found that the
manganese-induced increase in acetylcholine esterase ac-
tivity and decrease in choline acetyltransferase activity
were restored by taurine treatment, which is consistent
with previous studies [27]. Muramatsu and his coworkers
reported that taurine stabilized excitable membrane and
suppressed the release of acetylcholine and norepineph-
rine at synapses [28]. In addition, the level of taurine is de-
creased in the brain of Alzheimer’s patients. Moreover,
taurine supplement increased acetylcholine level in the ex-
perimental animal brain [29]. In a study by Hayate and his
colleagues, taurine has been shown to restore the learning
and memory deficits induced by intracerebroventricularly
injection of streptozotocin by increasing the expression of
ChAT in hippocampus [25]. All these evidences support
that taurine improves the learning and memory function
by controlling the level of acetylcholine.
In the proteomic analysis, we identified 9 differentially
expressed proteins between the control, manganese, and
taurine plus manganese groups. Among them, dynactin
participates in the development of Huntington's disease,
which is an autosomal dominant neurodegenerative dis-
order that affects primarily the striatum and cerebral cor-
tex. The function of prepro-A-type allatostatin(N) is not
clear yet. The rest of seven proteins all locate in cytoplasm
and involve in the energy metabolism and oxidative stress
pathways, implying that taurine serves as an antioxidant
to protect the oxidative damages induced by manganese.
Several lines of evidences have shown that taurine supple-
ment protects oxidative damages induced by toxic com-
pounds such as ethanol [25], lead [26] and β-amyloid [27].
Figure 3 Examples of differentially expressed proteins in hippocampus found by 2-DE. (A) Representative 2D gel images from Mn and
taurine + Mn. Molecular weight ranges from 250 KD to 10 KD and PIs ranges between 4 and 7. (B) Representative spots between the control and
Mn treated groups. The control group as above line and 8w Mn administration group as below line. a(8C-M2):peroxiredoxin-6; b(8C-M8):dynactin
subunit 3 isoform B; c(8C-M12):L-lactate dehydrogenase B chain.
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by improving electron transport chain activity which is
also responsible for ATP synthesis [28]. Mg competes with
Mn to form MgATP, which serves as a substrate for
ATPase in the synthesis of ATP [29]. Therefore, it isTable 1 9 identified viariation spots among different groups
Spot no. Protein identified Accession n
8C-M 1 Mu-crystallin homolog gi|16758840
8C-M 2 Peroxiredoxin-6 gi|16758348
8C-M 3 Actin-related protein 3 homolog gi|161728791
8C-M 4 Calreticulin precursor gi|11693172
8C-M 5 Secernin-1 gi|68163565
8C-M 8 Dynactin subunit 3 isoform B gi|227116275
8C-M 12 L-lactate dehydrogenase B chain gi|6981146
8 M-P 4 Prepro-A-type allatostatin(N) gi|152125945
8 M-P 8 Glial fibrillary acidic protein delta gi|5030428possible that taurine facilitates MgATP formation in the
presence of Mn. Glial fibrillary acidic protein (GFAP) is a
classic astrocyte marker and up-regulated upon exposure
of many toxicants. Here, we observed that the expression
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some studies have indicated that taurine treatment was
associated with a reduced level of GFAP in rats after 3-
nitropropionic acid exposure in the xenotransplantated
neurons derived from the human teratocarcinoma cell
line [30]. This discrepancy could be resulted from the
difference in the length of taurine treatment. Previous
studies have shown that the expression of GFAP changes
in a relatively slow rate [31,32]. Hence, it may take a lon-
ger treatment period before the expression of GFAP to de-
crease. The differentially expressed proteins we identified
in this study still need to be further validated to elaborate
their roles in the protective effects of taurine on cognitive
deficit.
Conclusions
In summary, taurine restores the activity of AChT and
ChAT, which are critical for the regulation of acetylcho-
line. We have identified seven differentially expressed
proteins specifically induced by manganese and two pro-
teins induced by taurine from the rat hippocampus. Our
results support that taurine improves the impaired learn-
ing and memory ability caused by excessive exposure of
manganese.
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